Literature DB >> 8702978

Isolation and sequencing of the rho gene from Streptomyces lividans ZX7 and characterization of the RNA-dependent NTPase activity of the overexpressed protein.

C J Ingham1, I S Hunter, M C Smith.   

Abstract

The gene for transcription termination factor Rho was isolated from Streptomyces lividans ZX7. It encoded a 77-kDa polypeptide (Rho 77) with considerable homology to known Rho factors. An atypical hydrophilic region of 228 residues was found within the N-terminal RNA-binding domain. Only Rho from Micrococcus luteus and Mycobacterium leprae (closely related GC-rich Gram-positive bacteria) had an analogous sequence. Rho 77 was overexpressed in Escherichia coli and purified using an N-terminal hexahistidine-tag. Rho 77 displayed a broad RNA-dependent ATPase activity, with poly(C) RNA being no more than 4-fold more effective than poly(A). This contrasts with the ATPase activity of Rho from E. coli which is stimulated primarily by poly(C) RNA. Rho 77 was a general RNA-dependent NTPase, apparent Km values for NTPs were: GTP 0.13 mM, ATP 0.17 mM, UTP 1.1 mM, and CTP >2 mM. Rho 77 poly(C)-dependent ATPase activity was inhibited by heparin, unlike the E. coli Rho. The antibiotic bicyclomycin inhibited the in vitro RNA-dependent ATPase activity of Rho 77, did not inhibit growth of streptomycetes but delayed the development of aerial mycelia. N-terminal deletion analysis to express a truncated form of Rho (Rho 72, 72 kDa) indicated that the first 42 residues of Rho 77 were not essential for RNA-dependent NTPase activity and were not the targets of inhibition by heparin or bicyclomycin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702978     DOI: 10.1074/jbc.271.36.21803

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The transcription termination factor Rho is essential and autoregulated in Caulobacter crescentus.

Authors:  Valéria C S Italiani; Marilis V Marques
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

2.  ATP-dependent motor activity of the transcription termination factor Rho from Mycobacterium tuberculosis.

Authors:  François D'Heygère; Annie Schwartz; Franck Coste; Bertrand Castaing; Marc Boudvillain
Journal:  Nucleic Acids Res       Date:  2015-05-20       Impact factor: 16.971

3.  Transcription termination factor Rho is essential for Micrococcus luteus.

Authors:  W L Nowatzke; E Keller; G Koch; J P Richardson
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

4.  Depleting Mycobacterium tuberculosis of the transcription termination factor Rho causes pervasive transcription and rapid death.

Authors:  Laure Botella; Julien Vaubourgeix; Jonathan Livny; Dirk Schnappinger
Journal:  Nat Commun       Date:  2017-03-28       Impact factor: 14.919

5.  Implications of high level pseudogene transcription in Mycobacterium leprae.

Authors:  Diana L Williams; Richard A Slayden; Amol Amin; Alejandra N Martinez; Tana L Pittman; Alex Mira; Anirban Mitra; Valakunja Nagaraja; Norman E Morrison; Milton Moraes; Thomas P Gillis
Journal:  BMC Genomics       Date:  2009-08-25       Impact factor: 3.969

6.  Comparative analysis of non-coding RNAs in the antibiotic-producing Streptomyces bacteria.

Authors:  Matthew J Moody; Rachel A Young; Stephanie E Jones; Marie A Elliot
Journal:  BMC Genomics       Date:  2013-08-16       Impact factor: 3.969

7.  Mycobacterium tuberculosis Rho is an NTPase with distinct kinetic properties and a novel RNA-binding subdomain.

Authors:  Anirban Mitra; Rachel Misquitta; Valakunja Nagaraja
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

8.  Study of bicyclomycin biosynthesis in Streptomyces cinnamoneus by genetic and biochemical approaches.

Authors:  Jerzy Witwinowski; Mireille Moutiez; Matthieu Coupet; Isabelle Correia; Pascal Belin; Antonio Ruzzini; Corinne Saulnier; Laëtitia Caraty; Emmanuel Favry; Jérôme Seguin; Sylvie Lautru; Olivier Lequin; Muriel Gondry; Jean-Luc Pernodet; Emmanuelle Darbon
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.